Stopping Neurodegeneration with Precision Vaccines
Date: 2026-06-24
Can vaccines stop neurodegeneration before irreversible damage occurs? In an interview with Inside Precision Medicine, Alzinova CEO Tord Labuda discusses how precision vaccines targeting toxic amyloid-beta oligomers could offer a new approach to Alzheimer's disease.
By activating the body’s own immune system against the underlying drivers of neurodegeneration, the goal is to slow disease progression and preserve cognitive function through a more accessible and sustainable treatment strategy.